Advertisement

Topics

CryoLife, Inc. Company Profile

11:31 EDT 22nd September 2017 | BioPortfolio


News Articles [9 Associated News Articles listed on BioPortfolio]

CryoLife to Present at 37th Annual Canaccord Genuity Growth Conference

ATLANTA, Aug. 2, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in th...

CryoLife to Present at Two Investor Conferences in September 2017

ATLANTA, Sept. 18, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that Pat Mac...

CryoLife Announces Release Date and Teleconference Call Details for 2017 Second Quarter Financial Results

ATLANTA, July 10, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2017 second quarter financial...

CryoLife to Present at Upcoming Investor Conferences in New York

ATLANTA, Nov. 3, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that Steven G. Anderso...

CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results

ATLANTA, Feb. 2, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today that 2011 fourth ...

CryoLife's (CRY) CEO Pat Mackin on Q2 2017 Results - Earnings Call Transcript

CryoLife Reports Second Quarter 2017 Financial Results

ATLANTA, July 24, 2017 /PRNewswire/ -- Second Quarter Highlights: Revenues Increased Two Percent Year-over-Year to $47.8 Million; Non-GAAP Revenues Increased Four Percent Year-over-Year...

Global Tissue Engineering Market Research 2011 2022 [Report Updated: 19042017] Prices from USD $2240

SummaryThe Global Tissue Engineering market is estimated to reach 13.9 Billion USD in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

CryoLife, Inc.

CryoLife Inc.

Founded in 1984, CryoLife was the first company to commercially develop the ultra-low temperature preservation of viable human heart valves for transplant. Since then, we have been engaged in an excit...

More Information about "CryoLife, Inc." on BioPortfolio

We have published hundreds of CryoLife, Inc. news stories on BioPortfolio along with dozens of CryoLife, Inc. Clinical Trials and PubMed Articles about CryoLife, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CryoLife, Inc. Companies in our database. You can also find out about relevant CryoLife, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record